The Most Lucrative Market for CROs in the Asia Pacific in 2015

The Most Lucrative Market for CROs in the Asia Pacific in 2015

RELEASE DATE
04-Mar-2015
REGION
Asia Pacific
Research Code: 9A35-00-31-00-00
SKU: LS00067-AP-MR_16908

$500.00

Special Price $375.00 save 25 %

In stock
SKU
LS00067-AP-MR_16908

$500.00

$375.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of vital signs highlights the APAC pharmaceutical and CRO landscape, attractiveness by phase of development, and lucrative markets to watch.

Table of Contents

This week's issue

Related Research
This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.
More Information
No Index No
Podcast No
Author Sanjeev Kumar
WIP Number 9A35-00-31-00-00
Is Prebook No